CINECA IRIS Institutional Research Information System

SCHIRINZI, ERIKA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.710
AS - Asia 865
EU - Europa 521
SA - Sud America 153
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 43
Totale 5.360
Salva come PNG Salva come JPEG
Nazione #
CA - Canada 2.320
US - Stati Uniti d'America 1.369
SG - Singapore 301
CN - Cina 222
IT - Italia 183
BR - Brasile 131
HK - Hong Kong 129
SE - Svezia 86
VN - Vietnam 78
DE - Germania 54
FR - Francia 42
CI - Costa d'Avorio 29
GB - Regno Unito 27
BG - Bulgaria 26
FI - Finlandia 25
AT - Austria 19
IN - India 19
JP - Giappone 19
RU - Federazione Russa 17
BD - Bangladesh 14
TR - Turchia 14
KR - Corea 12
NL - Olanda 10
MX - Messico 9
MA - Marocco 8
PL - Polonia 8
AR - Argentina 7
ID - Indonesia 7
PK - Pakistan 7
ZA - Sudafrica 7
SN - Senegal 6
UA - Ucraina 5
CH - Svizzera 4
EC - Ecuador 4
EG - Egitto 4
NG - Nigeria 4
NP - Nepal 4
PH - Filippine 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CL - Cile 3
ES - Italia 3
IQ - Iraq 3
IR - Iran 3
KZ - Kazakistan 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
BE - Belgio 2
CR - Costa Rica 2
DZ - Algeria 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
LY - Libia 2
MY - Malesia 2
NI - Nicaragua 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
TH - Thailandia 2
TN - Tunisia 2
VE - Venezuela 2
AM - Armenia 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
Totale 5.318
Salva come PNG Salva come JPEG
Città #
Montreal 2.307
Ashburn 192
Singapore 178
Dallas 170
Hong Kong 129
Santa Clara 100
San Jose 94
Fairfield 62
Chandler 60
Beijing 56
Shanghai 51
Los Angeles 43
Seattle 38
Council Bluffs 37
Milan 37
Woodbridge 37
New York 35
Houston 34
Cambridge 32
Munich 30
Abidjan 29
Sofia 25
Florence 24
Ann Arbor 22
Boardman 22
Wilmington 22
Hanoi 21
Hefei 21
Lauterbourg 17
Tokyo 17
Ho Chi Minh City 16
Princeton 15
Colorado Springs 14
Lawrence 14
Vienna 14
Buffalo 13
Turku 13
Medford 12
Seoul 11
Frankfurt am Main 10
Pisa 10
Helsinki 9
Istanbul 9
São Paulo 9
London 8
Ogden 8
Orem 8
Redondo Beach 8
Rome 8
Casablanca 7
Chicago 7
Nuremberg 7
Toronto 7
Dakar 6
Genoa 6
Warsaw 6
Dhaka 5
Lucca 5
Salvador 5
Stockholm 5
Baltimore 4
Boulder 4
Brooklyn 4
Denver 4
Fuzhou 4
Guarulhos 4
Haiphong 4
Johannesburg 4
Lagos 4
Macerata 4
Norwalk 4
Padova 4
Phoenix 4
Serra 4
Venice 4
Amsterdam 3
Baku 3
Biên Hòa 3
Boston 3
Caloocan City 3
Des Moines 3
Düsseldorf 3
Lahore 3
Las Vegas 3
Mexico City 3
Montevideo 3
Piscataway 3
Recife 3
Redwood City 3
Rio de Janeiro 3
The Dalles 3
Vancouver 3
Vicenza 3
Wuhan 3
Zurich 3
Anápolis 2
Baghdad 2
Bengaluru 2
Brasília 2
Bucharest 2
Totale 4.347
Salva come PNG Salva come JPEG
Nome #
A Clinical Tool for Prognosis and Speech Rehabilitation in Dysarthric Patients: The DESIRE Project 2.550
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 225
Risk factors for CIDP: antecedent events, lifestyle and dietary habits. Data from the Italian CIDP database 213
Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 207
A novel family with axonal Charcot-Marie-Tooth disease caused by a mutation in the EGR2 gene 146
Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 141
Exercise-Related Oxidative Stress as Mechanism to Fight Physical Dysfunction in Neuromuscular Disorders 134
Exercise therapy in muscle diseases: open issues and future perspectives 122
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study 119
Biomolecules of Muscle Fatigue in Metabolic Myopathies 114
E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 3rd eNMD Congress: Pisa, Italy, 29–30 October 2021 113
Statin therapy in ischemic stroke patients with atrial fibrillation: Efficacy and safety outcomes 112
Fatigue as a common signature of inflammatory myopathies: clinical aspects and care 109
Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy 108
Frailties and critical issues in neuromuscular diseases highlighted by SARS-CoV-2 pandemic: how many patients are still "invisible"? 105
Intravenous immunoglobulin in the treatment of sporadic inclusion body myositis: time for new evidence? 102
The use of digital tools in rare neurological diseases towards a new care model: a narrative review 101
CSF sphingomyelin: A new biomarker of demyelination in the diagnosis and management of CIDP and GBS 101
Telemedicine and remote monitoring in neuromuscular diseases: Challenges and opportunities 100
E-Health Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 1st eNMD Congress: Nice, France, March 22-23, 2019 99
Impact of environmental factors and physical activity on disability and quality of life in CIDP 95
Post-therapy normalization of brain FDG-PET in Morvan's syndrome 89
Therapeutic opportunities and clinical outcome measures in Duchenne muscular dystrophy 81
null 74
Totale 5.360
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.939
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022136 0 4 0 8 21 18 5 4 10 8 19 39
2022/2023263 27 40 28 9 19 26 3 22 55 0 24 10
2023/20242.532 12 31 25 8 21 28 27 8 2 2.310 25 35
2024/2025823 0 32 33 46 72 62 86 52 64 85 126 165
2025/20261.206 81 165 151 139 135 88 158 60 64 96 34 35
2026/202786 24 62 0 0 0 0 0 0 0 0 0 0
Totale 5.360